D.A. Davidson & Co. Biogen Inc. Transaction History

D.A. Davidson & Co.

$11.2 Billion
Q2 2024

A detailed history of D.A. Davidson & Co. transactions in Biogen Inc. stock. As of the latest transaction made, D.A. Davidson & Co. holds 3,196 shares of BIIB stock, worth $644,952. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,196

Previous 2,031 57.36%

Holding current value

$644,952

Previous $437,000 69.34%

% of portfolio

0.01%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$190.52 - $236.72 $221,955 - $275,778	1,165 Added 57.36%	3,196 $740,000
Q1 2024 May 13, 2024	SELL	$212.02 - $267.71 $11,449 - $14,456	-54 Reduced 2.59%	2,031 $437,000
Q4 2023 Feb 09, 2024	SELL	$222.59 - $267.94 $164,716 - $198,275	-740 Reduced 26.19%	2,085 $539,000
Q3 2023 Nov 08, 2023	BUY	$253.3 - $285.89 $147,673 - $166,673	583 Added 26.0%	2,825 $726,000
Q2 2023 Aug 10, 2023	SELL	$275.25 - $318.06 $20,643 - $23,854	-75 Reduced 3.24%	2,242 $638,000
Q1 2023 Apr 25, 2023	SELL	$256.56 - $292.34 $582,647 - $663,904	-2,271 Reduced 49.5%	2,317 $644,000
Q4 2022 Feb 03, 2023	SELL	$252.44 - $306.72 $830,275 - $1.01 Million	-3,289 Reduced 41.75%	4,588 $1.27 Million
Q3 2022 Nov 07, 2022	SELL	$194.69 - $268.46 $851,768 - $1.17 Million	-4,375 Reduced 35.71%	7,877 $2.1 Million
Q2 2022 Jul 28, 2022	SELL	$187.54 - $223.02 $219,796 - $261,379	-1,172 Reduced 8.73%	12,252 $2.5 Million
Q1 2022 May 12, 2022	BUY	$193.77 - $244.14 $153,272 - $193,114	791 Added 6.26%	13,424 $2.83 Million
Q4 2021 Jan 31, 2022	BUY	$223.92 - $287.77 $2.05 Million - $2.63 Million	9,142 Added 261.87%	12,633 $3.03 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $20,658 - $26,940	-73 Reduced 2.05%	3,491 $988,000
Q2 2021 Aug 10, 2021	SELL	$259.0 - $414.71 $325,822 - $521,705	-1,258 Reduced 26.09%	3,564 $1.23 Million
Q1 2021 May 07, 2021	BUY	$242.95 - $284.63 $643,088 - $753,415	2,647 Added 121.7%	4,822 $1.35 Million
Q4 2020 Feb 10, 2021	SELL	$236.26 - $355.63 $71,114 - $107,044	-301 Reduced 12.16%	2,175 $533,000
Q3 2020 Nov 02, 2020	BUY	$264.77 - $305.71 $14,827 - $17,119	56 Added 2.31%	2,476 $702,000
Q2 2020 Aug 10, 2020	SELL	$258.66 - $342.55 $17,588 - $23,293	-68 Reduced 2.73%	2,420 $647,000
Q1 2020 May 05, 2020	BUY	$268.85 - $341.04 $12,098 - $15,346	45 Added 1.84%	2,488 $787,000
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $11,443 - $15,811	-52 Reduced 2.08%	2,443 $725,000
Q3 2019 Nov 05, 2019	SELL	$217.44 - $243.88 $31,963 - $35,850	-147 Reduced 5.56%	2,495 $581,000
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $4.37 Million - $4.81 Million	-19,917 Reduced 88.29%	2,642 $618,000
Q1 2019 May 13, 2019	SELL	$216.71 - $338.96 $127,642 - $199,647	-589 Reduced 2.54%	22,559 $5.35 Million
Q4 2018 Jan 29, 2019	SELL	$278.5 - $352.75 $174,898 - $221,527	-628 Reduced 2.64%	23,148 $6.97 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $27,589 - $36,080	94 Added 0.4%	23,776 $8.4 Million
Q2 2018 Aug 02, 2018	BUY	$257.52 - $306.91 $956,171 - $1.14 Million	3,713 Added 18.59%	23,682 $6.87 Million
Q1 2018 May 04, 2018	SELL	$260.13 - $367.91 $48,124 - $68,063	-185 Reduced 0.92%	19,969 $5.47 Million
Q4 2017 Feb 08, 2018	BUY	$307.64 - $344.58 $38,455 - $43,072	125 Added 0.62%	20,154 $6.42 Million
Q3 2017 Nov 08, 2017	BUY	$281.15 - $329.69 $9,559 - $11,209	34 Added 0.17%	20,029 $6.27 Million
Q2 2017 Aug 11, 2017	BUY	N/A	19,995	19,995 $0

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $29.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account